RNF113B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10345
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human RNF113B (NP_849192). Peptide sequence HDHIYRGIHSYLRYLKPKDTSMGNSSSGMARKGPIRAPGHLRATVRWDYQ
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
36 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for RNF113B Antibody
Western Blot: RNF113B Antibody [NBP3-10345]
Western Blot: RNF113B Antibody [NBP3-10345] - Western blot analysis using NBP3-10345 on Human ACHN as a positive control. Antibody Titration: 0.2-1 ug/mlApplications for RNF113B Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: RNF113B
Alternate Names
bA10G5.1, MGC26599, ring finger protein 113B, Zinc finger protein 183-like 1RNF161ZNF183L1
Gene Symbol
RNF113B
Additional RNF113B Products
Product Specific Notices for RNF113B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...